These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 9563008

  • 21. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 22. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R, Jewett A, Bonavida B.
    Gynecol Oncol; 1996 Aug; 62(2):282-91. PubMed ID: 8751562
    [Abstract] [Full Text] [Related]

  • 23. Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line.
    Siddik ZH, Mims B, Lozano G, Thai G.
    Cancer Res; 1998 Feb 15; 58(4):698-703. PubMed ID: 9485023
    [Abstract] [Full Text] [Related]

  • 24. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis.
    Katayose D, Wersto R, Cowan KH, Seth P.
    Cell Growth Differ; 1995 Oct 15; 6(10):1207-12. PubMed ID: 8845297
    [Abstract] [Full Text] [Related]

  • 25. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM.
    Anticancer Res; 2000 Oct 15; 20(6B):4463-71. PubMed ID: 11205289
    [Abstract] [Full Text] [Related]

  • 26. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.
    Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630
    [Abstract] [Full Text] [Related]

  • 27. Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity.
    Ju JF, Banerjee D, Lenz HJ, Danenberg KD, Schmittgen TC, Spears CP, Schönthal AH, Manno DJ, Hochhauser D, Bertino JR, Danenberg PV.
    Clin Cancer Res; 1998 May 09; 4(5):1315-22. PubMed ID: 9607592
    [Abstract] [Full Text] [Related]

  • 28. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX, Ngo D, Brade AM, Klamut HJ.
    Cancer Gene Ther; 1999 May 09; 6(2):179-90. PubMed ID: 10195885
    [Abstract] [Full Text] [Related]

  • 29. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L, Di Mario F, Botti P, Ragazzi E, Martelli M, Kelland L.
    Biochem Pharmacol; 2007 Jun 30; 74(1):20-7. PubMed ID: 17466278
    [Abstract] [Full Text] [Related]

  • 30. UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.
    Husain A, Yan XJ, Rosales N, Aghajanian C, Schwartz GK, Spriggs DR.
    Clin Cancer Res; 1997 Nov 30; 3(11):2089-97. PubMed ID: 9815601
    [Abstract] [Full Text] [Related]

  • 31. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R.
    Cancer Res; 1999 Jun 15; 59(12):2829-33. PubMed ID: 10383141
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The impact of p53 status on cellular sensitivity to antifolate drugs.
    Lu X, Errington J, Curtin NJ, Lunec J, Newell DR.
    Clin Cancer Res; 2001 Jul 15; 7(7):2114-23. PubMed ID: 11448931
    [Abstract] [Full Text] [Related]

  • 34. Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells.
    Katayose D, Wersto R, Cowan K, Seth P.
    Biochem Biophys Res Commun; 1995 Oct 13; 215(2):446-51. PubMed ID: 7487976
    [Abstract] [Full Text] [Related]

  • 35. Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins.
    Roy G, Horton JK, Roy R, Denning T, Mitra S, Boldogh I.
    Oncogene; 2000 Jan 06; 19(1):141-50. PubMed ID: 10644989
    [Abstract] [Full Text] [Related]

  • 36. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH, Li P, Klamut H, Liu FF.
    Clin Cancer Res; 1997 Apr 06; 3(4):507-14. PubMed ID: 9815713
    [Abstract] [Full Text] [Related]

  • 37. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.
    Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW, Cowan KH, Seth P.
    Urology; 1995 Dec 06; 46(6):843-8. PubMed ID: 7502427
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin.
    Chekhun VF, Lukyanova NY, Urchenko OV, Kulik GI.
    Exp Oncol; 2005 Sep 06; 27(3):191-5. PubMed ID: 16244579
    [Abstract] [Full Text] [Related]

  • 40. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.
    Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.